June 25, 2008 - Health Canada - Medical Device Bureau, Therapeutic Products Programme, has approved the use of the ATS Open Pivot AP360 Mechanical Heart Valve, allowing ATS to offer a valve designed according to specific valve selection criteria of cardiac surgeons.

June 25, 2008 – Global Therapeutics received CE Mark approval for a new cobalt chromium bare metal coronary stent, the GTX Coronary Stent System, which targets the bare metal stent market.

The GTX stent is reportedly engineered to eliminate the technical challenges, such as recoil, stent balloon retention and stent spring-back, that have been associated with earlier cobalt chromium stent designs currently on the market.”

June 25, 2008 - Cardiologists completed the 1,300th worldwide procedure utilizing the TandemHeart System, said manufacturer CardiacAssist, marking the increased acceptance of the device and use by cardiologists and surgeons.

June 25, 2008 - Medtronic reported that all Vision 3D implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy-defibrillators (CRT-Ds) are now compatible with the Medtronic CareLink Network.

June 20, 2008 - HemoCue AB reported that the FDA granted the HemoCue Albumin 201 System, a quantitative point-of-care test for screening, diagnosing and monitoring microalbuminuria, a CLIA waiver, enabling the use of the test kit in any healthcare facility with a CLIA Certificate of Waiver in the U.S.
Microalbuminuria may indicate the presence of chronic kidney disease (CKD), and the risk of developing cardiovascular disease in patients with or without diabetes or hypertension.

IntelliDOT Corp. received FDA 510(k) clearance for the IntelliDOT Blood Product Administration (IntelliDOT BPA) for commercial sale.

June 24, 2008 - IntelliDOT Corp. said yesterday the FDA granted 510(k) clearance for the IntelliDOT Blood Product Administration (IntelliDOT BPA) for commercial sale.

June 23, 2008 - For more than a decade, the drug called tPA has proven its worth as the most effective emergency treatment for the most common kind of stroke, but its promise is blemished by two facts: tPA can cause dangerous bleeding in the brain, and its brain-saving power fades fast after the third hour of a stroke.

Now, a new paper published recently online in Nature Medicine reveals why tPA has these limitations. It also gives tantalizing evidence about how those problems might be overcome, if a stroke victim first takes a drug currently used to treat leukemia.

June 20, 2008 - Freescale Semiconductor and Monebo Technologies recently forged a partnership to deliver a comprehensive platform for medical equipment using electrocardiogram (ECG) on a chip technology to enable medical equipment manufacturers to develop easy-to-use ECG monitoring tools.


Human error is one of patient safety’s biggest enemies and while clinicians try not to make mistakes, they frequently have their attention pulled in several directions at once. Computers on the other hand can be programmed to look for mistakes to help avert problems, which is the main reason advocates say electronic health records (EHRs) are needed to make vast improvements in patient safety.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now